Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.87 USD | -0.84% | +5.32% | -21.65% |
May. 29 | Zentalis Pharmaceuticals Announces Appointment of Luke Walker, M.D., to Board of Directors | CI |
May. 24 | Zentalis Says Azenosertib Combo Shows 'Promise' in Relapsed Osteosarcoma Trial | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 13.00 | 16.49 | 17.15 |
Spread/Res. | -8.69% | -28.02% | -30.79% |
Spread/Supp. | +9.60% | +9.60% | +20.63% |
Support | 10.83 | 10.83 | 9.840 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ZNTL Stock
- Charts Zentalis Pharmaceuticals, Inc.